Table F-3Rankings of comparative efficacy, standard deviations, and 95% credible intervals; trials (n=134) specifying vasomotor symptoms as a primary outcome and requiring symptoms

TreatmentMean RankSD95% CrI
E-High1.90.6(1-3)
E-Standard1.30.5(1-2)
E-Low/Ultralow3.00.4(2-4)
SSRI/SNRI5.01.1(4-7)
Gabapentin5.71.4(3-8)
Isoflavones5.61.1(4-8)
Black Cohosh6.61.3(4-8)
Ginseng7.11.5(4-9)
Placebo8.90.3(8-9)

SD: standard deviation; CrI: credible interval; E: estrogen; SSRI: selective serotonin reuptake inhibitor; SNRI: serotonin and norepinephrine reuptake inhibitor.

From: Appendix F, Vasomotor Symptom Supplemental Tables and Plots

Cover of Menopausal Symptoms: Comparative Effectiveness of Therapies
Menopausal Symptoms: Comparative Effectiveness of Therapies [Internet].
Comparative Effectiveness Reviews, No. 147.
Grant MD, Marbella A, Wang AT, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.